Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Dicerna Pharmaceutic (DRNA)

5.51 +0.26 (+4.95%)

10/20/2017  4:00pm

Open:

5.25

Pre. Close:

5.25

High:

5.71

Low:

5.24

Volume:

91,363

Market Cap:

114.85M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.85 - 5.93

5.93 - 6.1

Low:

4.98 - 5.03

5.03 - 5.13

Close:

5.33 - 5.47

5.47 - 5.77

Technical analysis  (as of: 2017-10-20 4:35:25 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 7.88     One year: 9.21

Support:

Support1: 4.91    Support2: 3.78

Resistance:

Resistance1: 6.75    Resistance2: 7.88

Pivot:

5.81

Moving Averages:

MA(5): 5.34     MA(20): 5.64

MA(100): 3.84     MA(250): 3.36

MACD:

MACD(12,26): 0.28     Signal(12,26,9): 0.42

%K %D:

%K(14,3): 21.44     %D(3): 24.46

RSI:

RSI(14): 57.47

52-Week:

High: 6.75  Low: 2.42  Change(%): 45.0

Average Vol(K):

3-Month: 17083  10-Days 8973

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DRNA has closed above bottom band by 32.5%. Bollinger Bands are 51.4% wider than normal. The large width of the bands suggest high volatility as compared to DRNA's normal range. The bands have been in this wide range for 22 bars. This is a sign that the current trend might continue.

Headline News

Tue, 09 May 2017 00:31:12 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q1 2017 Results ...

Fri, 11 Aug 2017 02:37:30 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q2 2017 Results ...

Sat, 21 Oct 2017 02:26:15 GMT
Tale of the Tape: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Moves -1.25%

Mon, 16 Oct 2017 11:35:32 GMT
Dicerna Pharma (DRNA) Files Clinical Trial Application for DCR-PHXC, for Phase ...

Wed, 18 Oct 2017 18:22:30 GMT
Can These Stocks Continue To Spark? – Argos Therapeutics, Inc. (ARGS), Dicerna ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

12.51

% Held by Insiders

1.62

% Held by Institutions

72.58

Shares Short (K)

533

Shares Short Prior Month (K)

496

Stock Financials

EPS

-3.200

EPS Est. Current Year

-2.700

EPS Est. Next Year

-2.760

EPS Est. Next Quarter

-0.690

Forward EPS

-2.764

Book Value (p.s.)

0.640

PEG Ratio

Profit Margin

Operating Margin

-8517.50

Return on Assets (ttm)

-42.8

Return on Equity (ttm)

-76.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.014

Sales Per Share

EBITDA (p.s.)

-2.743

Qtrly Earnings Growth

Operating Cash Flow (M)

-50.10

Levered Free Cash Flow (M)

-28.50

FoxReading.com

Valuation

P/E

-1.72

P/E Growth Ratio

0.05

P/BV

8.61

P/S

3827613440.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.